Investors

Company Information

Company Profile

Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric Biosciences' robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

IR Contacts

Investor Relations
Valter Pinto/Allison Soss
KCSA Strategic Communications
EnvericBio@kcsa.com
(212) 896-1254

Media
Caitlin Kasunich/Raquel Cona
KCSA Strategic Communications
EnvericBio@kcsa.com
(212) 896-1241

Auditor
Marcum LLP
750 3rd Avenue, 11th Floor
New York, NY 10017
(212) 485-5500

Transfer Agent
Equiniti
Contact Form
(800) 468-9716

U.S. Legal Council
Haynes and Boone, LLP
30 Rockefeller Plaza, 26th Floor
New York, NY 10112
(212) 659-7300

Frequently Asked Questions

What is Enveric Biosciences?

Enveric Biosciences (NASDAQ: ENVB) is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids, to provide supportive care for targeted, unmet medical needs, both extending and enhancing patient quality of life.

What year was Enveric Biosciences founded?

Enveric Biosciences was incorporated in the state of Delaware on January 11, 2018 and completed its organization, formation, and initial capitalization activities effective as of June 7, 2018

Where is Enveric Biosciences headquartered?

4851 Tamiami Trail N, Suite 200, Naples, FL 34103

What are Enveric Biosciences industry classifications?

Sector: Biotechnology
SIC: 2834 – Pharmaceutical Preparations

When did Enveric Biosciences go public?

Enveric Biosciences became a publicly traded company through a tender offer and reverse capitalization on December 23, 2020.

How do I invest in Enveric Biosciences?

You can purchase shares in the Company through a registered broker-dealer of your choice. You cannot purchase units directly from the Company. For information about investing in stocks, you may want to consult a financial professional to explain to you the risks and suitability when investing.

Does Enveric Biosciences offer a Direct Stock Purchase Plan (DSPP or DRIP)?

We do not offer a direct stock purchase or dividend reinvestment program.

Does Enveric Biosciences pay a dividend?

Enveric Biosciences does not anticipate paying any cash dividends in the foreseeable future.

Who is Enveric Biosciences’ transfer agent?

Equinity can be reached by telephone at (800) 468-9716.

Where do I find SEC filings?

You can go to the official SEC website or you can view them in the Investors section of this website.